Warning message
There is currently a suspension or adjustment to some of our activities due to COVID-19. For full details please visit our
Activities in response to COVID-19 information page.
What's new
ARPANSA has released an action plan outlining activities that will be undertaken as part of the Australian Government’s Electromagnetic Energy (EME) Program.
Earlier this year, the Australian Communications and Media Authority (ACMA) measured the level of radiofrequency electromagnetic energy (RF EME) the public is exposed to at 59 small cell sites across Australia.
Water can include naturally-occurring radioactive material leached from rocks and soil, and it’s important that guidelines are in place to ensure the safe management of our water supply.
ARPANSA is currently seeking nominations for members of both the Radiation Health Committee and the Nuclear Safety Committee.
ARPANSA has endorsed the International Commission on Non-Ionizing Radiation Protection Principles for non-ionizing radiation protection.
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has issued a product warning to advise consumers of the dangers of portable devices that emit ultraviolet radiation (UVR).
ARPANSA’s Dr Ken Karipidis chaired a committee of the International Commission on Non-Ionising Radiation Protection (ICNIRP) to develop a statement on exposure to non-ionising radiation for cosmetic purposes.
ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out audits on a new Elekta Unity MRI-Linac in Townsville, Queensland before the treatment of the first patient.
Do you use, or are you exposed to radiation as part of your work? Our new suite of occupational exposure factsheets have been designed to keep you informed about the type of radiation you may be exposed to, any possible health effects and how to adequately protect yourself.
With the novel coronavirus (COVID-19) pandemic, some members of the public are concerned about the human immune system and whether it can be compromised by wireless telecommunications sources such as 5G.
On 27 March 2020, the CEO of ARPANSA, Dr Carl-Magnus Larsson, removed a licence condition from the ANSTO Nuclear Medicine (ANM) facility, allowing it to return to routine operation.
As a Federal Government Agency working under the Department of Health, ARPANSA is committed to supporting the health and safety of all Australians.
The International Commission on Non-ionizing Radiation Protection (ICNIRP) has released new guidelines for radiofrequency radiation protection.
ARPANSA has again collated data from radiation regulators around the country to provide a report on radiation safety and identify opportunities for improvement in the safe use of radiation, particularly in the medical sector.
The radiation dose from a CT scan, while low, is nonetheless assumed to contribute a small additional risk to a patient’s lifetime risk of cancer. ARPANSA's new reference levels show patients in Australia are receiving much lower doses than 5-10 years ago.
ARPANSA staff Sandra Sdraulig and Dr Stuart Henderson recently travelled to Antarctica to support ongoing monitoring of radionuclides and ultraviolet (UV) radiation in the environment.
Dr Ken Karipidis, Assistant Director Assessment and Advice at ARPANSA, has been appointed to the International Commission on Non-Ionizing Radiation Protection (ICNIRP) for the term of 2020 to 2024.
Recently, we participated in a study to review the ongoing impacts of nuclear tests conducted in the Montebello islands off the north coast of Western Australia.
Pages
